Table 4. DALY estimates for ZIKV.
YLLacute | YLDacute | YLLGBS | YLDGBS | YLLCZS | YLDCZS | YLDcare | YLDEPL | TOTAL | |
---|---|---|---|---|---|---|---|---|---|
AFRO | - | 1 (1–2) |
- | - | 92 (0–276) |
146 (0–219) |
48 (0–90) |
- |
287 (1–403) |
AMRO | 40 (40–60) |
96 (23–197) |
108 (0–206) |
5 (0–289) |
12,236 (9,384–45,632) |
22,734 (178–40,958) |
7,460 (118–17,364) |
16 (4–59) |
42,690 (10,058–77,884) |
EMRO | - | - | - | - | - | - | - | - | - |
EURO | - | - | - | - | 0 (0–92) |
73 (0–73) |
24 (0–30) |
- |
97 (0–104) |
SEARO | - | - | - | - | 0 (0–92) |
73 (0–73) |
24 (0–30) |
- |
97 (0–173) |
WPRO | - | 2 (2–5) |
- | 0 (0–15) |
276 (0–1,104) |
512 (0–951) |
168 (0–391) |
0 (0–1) |
958 (2–1,812) |
TOTAL | 40 (40–60) |
100 (26–203) |
108 (0–206) |
5 (0–304) |
12,604 (9,384–47,104) |
34,772 (178–42,275) |
7,724 (118–17,364) |
16 (4–61) |
44,130 (10,061–80,407) |
AFRO, WHO Africa region; AMRO, WHO Americas region; care, caregiver impact; CZS, congenital Zika syndrome; DALY, disability-adjusted life year; EMRO, WHO Eastern Mediterranean region; EPL, early pregnancy loss; EURO, WHO European region; GBS, Guillain–Barré syndrome; SEARO, WHO Southeast Asia region; WPRO, Western Pacific region; YLD, years lost to disability; YLL, years of life lost; ZIKV, Zika virus.